Factor XIa inhibition with asundexian after acute non-cardioembolic ischaemic stroke (PACIFIC-Stroke): an international, randomised, double-blind, placebo-controlled, phase 2b trial.
Shoamanesh A, Mundl H, Smith E, Masjuan J, Milanov I, Hirano T, Agafina A, Campbell B, Caso V, Mas J, Dong Q, Turcani P, Christensen H, Ferro J, Veltkamp R, Mikulik R, De Marchis G, Robinson T, Lemmens R, Stepien A, Greisenegger S, Roine R, Csiba L, Khatri P, Coutinho J, Lindgren A, Demchuk A, Colorado P, Kirsch B, Neumann-Haefelin C, Heenan L, Xu L, Connolly S, Hart R, PACIFIC-Stroke Investigators. Factor XIa inhibition with asundexian after acute non-cardioembolic ischaemic stroke (PACIFIC-Stroke): an international, randomised, double-blind, placebo-controlled, phase 2b trial. Lancet 2022; 400:997-1007.
02.09.2022
Factor XIa inhibition with asundexian after acute non-cardioembolic ischaemic stroke (PACIFIC-Stroke): an international, randomised, double-blind, placebo-controlled, phase 2b trial.
02.09.2022
Lancet 2022; 400:997-1007
Shoamanesh Ashkan, Mundl Hardi, Smith Eric E, Masjuan Jaime, Milanov Ivan, Hirano Teruyuki, Agafina Alina, Campbell Bruce, Caso Valeria, Mas Jean-Louis, Dong Qiang, Turcani Peter, Christensen Hanne, Ferro Jose M, Veltkamp Roland, Mikulik Robert, De Marchis Gian Marco, Robinson Thompson G, Lemmens Robin, Stepien Adam, Greisenegger Stefan, Roine Risto, Csiba Laszlo, Khatri Pooja, Coutinho Jonathan, Lindgren Arne G, Demchuk Andrew M, Colorado Pablo, Kirsch Bodo, Neumann-Haefelin Christoph, Heenan Laura, Xu Lizhen, Connolly Stuart J, Hart Robert G, PACIFIC-Stroke Investigators
Weiter
